Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biological drug
|
| gptkbp:approvalYear |
2001
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
L04AC03
|
| gptkbp:contraindication |
active infections
|
| gptkbp:genericName |
gptkb:anakinra
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kineret
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
Swedish Orphan Biovitrum
|
| gptkbp:mechanismOfAction |
interleukin-1 receptor antagonist
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
headache
injection site reaction neutropenia |
| gptkbp:usedFor |
gptkb:Still's_disease
gptkb:cryopyrin-associated_periodic_syndromes rheumatoid arthritis |
| gptkbp:bfsParent |
gptkb:Sobi
gptkb:anakinra |
| gptkbp:bfsLayer |
7
|